New EU HTA Guidance OKs Single-Arm Studies, But More Work Needed On Evidence Gaps

ADVANCED THERAPIES
Advanced therapies and orphan drugs will be the first products to undergo a joint clinical assessment from January 2025 • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

More from Geography